Pain Therapeutics’ opioid drug fails to gain FDA approvalThe US regulator has rejected Pain Therapeutics’ abuse-deterrent opioid painkiller drug, Remoxy, for the fourth time. In a Share XPain Therapeutics’ opioid drug fails to gain FDA approvalhttps://pharmaphorum.com/news/opioid-drug-fails-gain-fda-approval/
Pain Therapeutics conference is taking place in London next weekSMi Group reports: To reserve last available seats at the Pain Therapeutics Conference, head on to the event Share XPain Therapeutics conference is taking place in London next weekhttps://pharmaphorum.com/partner-content/pain-therapeutics-conference-is-taking-place-in-london-next-week/
Great time for pain research: exclusive interviews with industry expertsSMi Group reports: Ahead of 18th annual Pain Therapeutics Conference (London, 21 – 22 May) SMi Group have Share XGreat time for pain research: exclusive interviews with industry expertshttps://pharmaphorum.com/partner-content/great-time-for-pain-research-exclusive-interviews-with-industry-experts/
Explore innovative approaches and novel targets in analgesic medicineThe opioid crisis has cost the economy $1 trillion since 2001 in the USA alone, and the prospect Share XExplore innovative approaches and novel targets in analgesic medicinehttps://pharmaphorum.com/partner-content/explore-innovative-approaches-and-novel-targets-in-analgesic-medicine/
